Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma
Clinical trial NCT01152788 · COMPLETED
Trial details
- NCT number
- NCT01152788
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-05
- Primary completion
- 2014-11-25
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.